Inflammatory Marker Predicts Outcome of Oral Squamous Cell Carcinoma Receiving Chemo-Radiotherapy

BACKGROUND: Inflammation is involved in the progression of oral squamous cell carcinoma. We therefore postulate that a blood-based inflammatory marker, the neutrophil-to-lymphocyte ratio, could help to predict the prognosis in patients with oral squamous cell carcinoma receiving chemo-radiotherapy,...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Wei, Gao, Meng, Hu, Guangyuan, Yuan, Xun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718863/
https://www.ncbi.nlm.nih.gov/pubmed/33293860
http://dx.doi.org/10.2147/CMAR.S277927

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718863/
https://www.ncbi.nlm.nih.gov/pubmed/33293860
http://dx.doi.org/10.2147/CMAR.S277927

Ejemplares similares